Survival of patients with distal esophageal and gastric cardia tumors: A population-based analysis of gastroesophageal junction carcinomas

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 1, 2010, Pages 43-48

  Whitson, Bryan A ^a   Groth, Shawn S ^a   Li, Zhongze ^b   Kratzke, Robert A ^a   Maddaus, Michael A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CONFOUNDING VARIABLE; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; STOMACH TUMOR; SURVIVAL RATE; TUMOR LOCALIZATION;

ADENOCARCINOMA; AGED; CARDIA; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 73149105120     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.04.011     Document Type: Article

References (23)

1. Siewert J.R., and Stein H.J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85 (1998) 1457-1459
2. Greene F.L. AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
3. Surveillance, Epidemiology, and End Results (SEER) Program. Limited-use data (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. Available at: www.seer.cancer.gov. Accessed April 2008.
4. Fritz A., Percy C., Jack A., Shanmugaratnam K., Sobin L., Parkin D.M., et al. International classification of diseases for oncology. 3rd. ed. (2000), World Health Organization, Geneva
5. Ellis Jr. F.H., Heatley G.J., Krasna M.J., Williamson W.A., and Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 113 (1997) 836-848
6. Graham A.J., Finley R.J., Clifton J.C., Evans K.G., and Fradet G. Surgical management of adenocarcinoma of the cardia. Am J Surg 175 (1998) 418-421
7. Hagen J.A., DeMeester S.R., Peters J.H., Chandrasoma P., and DeMeester T.R. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234 (2001) 520-531
8. Mariette C., Castel B., Balon J.M., Van Seuningen I., and Triboulet J.P. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29 (2003) 588-593
9. Rudiger Siewert J., Feith M., Werner M., and Stein H.J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232 (2000) 353-361
10. Barbour A.P., Rizk N.P., Gonen M., Tang L., Bains M.S., Rusch V.W., et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246 (2007) 1-8
11. Ito H., Clancy T.E., Osteen R.T., Swanson R.S., Bueno R., Sugarbaker D.J., et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?. J Am Coll Surg 199 (2004) 880-886
12. Law S., Arcilla C., Chu K.M., and Wong J. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176 (1998) 286-290
13. Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79 (1999) 1522-1530
14. Hartgrink H.H., van de Velde C.J., Putter H., Bonenkamp J.J., Klein Kranenbarg E., Songun I., et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22 (2004) 2069-2077
15. Nakamura K., Ueyama T., Yao T., Xuan Z.X., Ambe K., Adachi Y., et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 70 (1992) 1030-1037
16. Sano T., Sasako M., Yamamoto S., Nashimoto A., Kurita A., Hiratsuka M., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 22 (2004) 2767-2773
17. Hulscher J.B., van Sandick J.W., de Boer A.G., Wijnhoven B.P., Tijssen J.G., Fockens P., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
18. Altorki N., Kent M., Ferrara C., and Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236 (2002) 177-183
19. Lerut T., Nafteux P., Moons J., Coosemans W., Decker G., De Leyn P., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240 (2004) 962-974
20. Macdonald J.S., Smalley S.R., Benedetti J., Hundahl S.A., Estes N.C., Stemmermann G.N., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
21. Graham A.J., Shrive F.M., Ghali W.A., Manns B.J., Grondin S.C., Finley R.J., et al. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 83 (2007) 1257-1264
22. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
23. Wijnhoven B.P., Siersema P.D., Hop W.C., van Dekken H., and Tilanus H.W. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86 (1999) 529-535